Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug Published 2023-06-02 Download video MP4 360p Recommendations 25:17 Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company 24:07 Novartis CEO Vas Narasimhan on The David Rubenstein Show 26:06 Looking For A Better Owner For Our India-Listed Biz: Novartis CEO | Exclusive | Global Dialogues 04:50 'Regulators are seeing the importance' of generic drugs, Sandoz CEO says 08:47 What's NEW in Breast Cancer Treatment in 2023 | Top Breast Cancer Docs Discuss Emerging Research 12:18 Why Widespread Tech Layoffs Keep Happening Despite A Strong U.S. Economy 22:42 How the Most Elite Spy Agency Operates 13:23 Private Equity’s Ruthless Takeover Of The Last Affordable Housing In America 29:24 2018 WMIF | 1:1 Fireside Chat: Vasant Narasimhan, MD, CEO, Novartis 31:10 СВІТАН: Це кінець! Путіна ВБ'ЮТЬ у Кремлі. Олігархи готові ЗУПИНИТИ ВІЙНУ. Почалися ТОРГИ за Донбас? 04:43 Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine 58:20 Think Fast, Talk Smart: Communication Techniques 09:48 Novartis CEO: Growth drivers performing well, but product exclusivity losses creating headwinds 15:13 BlackRock: The Conspiracies You Don’t Know 08:47 Gravitas Plus: How Big Pharma pushes dangerous drugs and reaps profits 32:24 Ep 61 - Vas Narasimhan: How New Data Fit Novartis’ Growth Plan 11:44 Talking culture transformation with Vas Narasimhan and Adam Grant Similar videos 01:15 Novartis CEO says FDA's extended approval of breast cancer drug is a 'landmark' for the firm 04:16 Novartis CEO Vas Narasimhan: Our medicines are starting to take market share and deliver on promises 03:45 Novartis not joining the 'frenzy' of weight loss drugs, CEO says 23:37 Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19 07:01 Novartis CEO: Nations pulling back on health care spending ‘has long-term consequences' 11:50 Novartis ‘focusing on high-end, innovative medicines,’ CEO says 01:21 Vas explains Radioligand Therapy (RLT) 02:06 Reimagining Breast Cancer 00:56 Vas Narasimhan, CEO of Novartis - The Importance of Serendipity And Mindset in R&D 06:12 Novartis CEO: Expect continued growth in 2023 01:43 Novartis CEO on Next Gen Alzheimer & Cancer Therapies 02:57 Artificial Intelligence gives cancer research a boost. 01:53 Time matters: Claire’s time for new experiences ¦ Advanced Breast Cancer 03:29 Novartis generated $40 billion in innovative medicine sales, says CEO 04:17 Novartis CEO: We expect our six key drugs to grow ahead of analyst expectations More results